Understanding Osteoarthritis: What is it?

At a Glance

Osteoarthritis is not simply cartilage wearing out: it is a whole-joint condition involving cartilage, underlying bone, and the joint lining. Understanding this can reduce fear of movement and support appropriately tailored activity to improve strength and pain.

For a long time, osteoarthritis (OA) was described simply as “wear and tear”—the inevitable result of a joint’s “tread” wearing thin over time. However, modern medicine now recognizes OA as a complex disease process involving the entire joint ^[1]. It is not just a passive thinning of cartilage (the slippery tissue that cushions the ends of your bones). Rather, it is a “whole-joint” disorder where the cartilage, bone, and joint lining change early and in parallel ^[2]^[3].

This shift in understanding is important because it means OA is not just a mechanical failure. It is a biological process where different tissues are “talking” to each other through chemical signals ^[4].

The “Whole-Joint” Environment

To understand OA, it helps to look at the joint as an interconnected system. When one part changes, the others respond:

Articular Cartilage: Cartilage damage is a hallmark of OA, but it does not happen in isolation. The cartilage breaks down as a result of mechanical stress and chemical “crosstalk” from other tissues ^[5]. Because cartilage lacks its own blood supply or nerves, changes here are deeply intertwined with the surrounding tissues ^[6].
Subchondral Bone: This is the layer of bone directly underneath the cartilage. In OA, this bone can become thicker or develop small growths called osteophytes (bone spurs) ^[7]. This bone isn’t just a silent foundation; it releases proteins that contribute to the tissue changes in the joint ^[8].
Synovium: This is the thin lining of the joint capsule. In many people with OA, this lining becomes inflamed—a condition called synovitis ^[9]. This inflammation can happen early in the disease and releases chemicals that contribute to the breakdown of the joint structure ^[10].
Inflammatory Signaling: The “crosstalk” between these tissues is driven by cytokines, which are small proteins that act as chemical messengers. In OA, messengers like IL-1β and IL-6 contribute to the structural changes over time ^[11]^[12].

A Global Perspective: Who is Affected?

Osteoarthritis is the most common form of arthritis worldwide. As of 2021, an estimated 607 million people were living with the condition globally ^[13].

Age of Onset: While OA is most frequently diagnosed after age 40, the risk increases steeply as we age ^[14]. It is not a strictly “old person’s” disease, but the cumulative effects of joint loading and biological changes over decades make it more prevalent in older populations ^[15].
Common Sites: The knee is the most commonly affected joint globally, followed by the hip and the hand ^[14]. OA also frequently affects the spine (often called spondylosis), though this is sometimes tracked separately in global health data ^[16].
Gender Differences: OA is generally more common in women than in men, particularly in the knees and hands ^[13]^[17].

The Psychological Impact: Moving Beyond Fear

If you are feeling fearful about your diagnosis, you are not alone. Many people experience kinesiophobia, which is a clinical term for the fear of movement ^[18]. It is a natural response: if a joint hurts when you move it, your brain tries to protect you by telling you to stop.

However, research shows that this fear can lead to a cycle of inactivity that actually worsens symptoms. Higher levels of movement fear are linked to greater disability and a lower quality of life ^[19]^[20]. It is also common to experience low mood alongside chronic joint pain. If you find yourself struggling with persistent sadness, anxiety, sleep disruption, or hopelessness, please seek help from your care team—these are valid and treatable aspects of living with chronic pain ^[21].

Understanding that your joints are not “wearing out” like a pair of shoes, but are instead part of a living biological system, can be empowering. Movement, when done at an appropriate, tailored dose, improves strength and reduces pain. Recognizing the “whole-joint” nature of OA is the first step in moving from a mindset of “protection through stillness” to one of “management through informed action.”

Common questions in this guide

Is osteoarthritis just wear and tear?

No. Osteoarthritis affects the whole joint, including the cushioning cartilage, the bone beneath it, and the joint lining. These tissues can change together and send chemical signals that contribute to joint damage and symptoms.

Can I keep moving if I have osteoarthritis?

Usually, movement at a level tailored to your condition can improve strength and reduce pain rather than automatically causing more damage. A healthcare professional can help you choose activities and adjust the amount if pain or stiffness changes.

Which joints are most often affected by osteoarthritis?

The knee is the most commonly affected joint worldwide, followed by the hip and hand. Osteoarthritis also often affects the spine, where it may be called spondylosis.

Why does osteoarthritis become more common with age?

Risk rises as people age because joint loading and biological changes accumulate over many years. Osteoarthritis is often diagnosed after age 40, but it is not limited to older adults.

Why might I be afraid to move with osteoarthritis?

Pain can create fear of movement, which may lead to inactivity. Greater fear of movement is linked with more disability and a lower quality of life, so discussing a gradual, appropriate activity plan with your care team can be helpful.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on osteoarthritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Given that OA involves the whole joint, which specific tissues are likely contributing to the changes in my joint?
2.Is the level of damage seen on my X-rays or scans consistent with the amount of pain I am feeling?
3.How can I stay active without causing more damage to the joint?
4.Are there specific activities or movements I should avoid, and which ones are most beneficial for my stage of OA?
5.What can we do to address the inflammation in my joint beyond just taking pain relievers?

References (21)

1
Unraveling Osteoarthritis: Mechanistic Insights and Emerging Therapies Targeting Pain and Inflammation.
Alad M, Yousef F, Epure LM, et al.
Biomolecules 2025; (15(6)) doi:10.3390/biom15060874.
PMID: 40563514
2
What is new in pharmacological treatment for osteoarthritis?
Gezer HH, Ostor A
Best practice & research. Clinical rheumatology 2023; (37(2)):101841 doi:10.1016/j.berh.2023.101841.
PMID: 37302928
3
Osteoarthritis: An Update on Diagnosis & Management.
Jhangiani P, Jain S, Neha K, Wakode S
Current rheumatology reviews 2025; (21(4)):367-385 doi:10.2174/0115733971317490240830101915.
PMID: 39279706
4
What drives osteoarthritis?-synovial versus subchondral bone pathology.
Hügle T, Geurts J
Rheumatology (Oxford, England) 2017; (56(9)):1461-1471 doi:10.1093/rheumatology/kew389.
PMID: 28003493
5
Bone-cartilage crosstalk: a conversation for understanding osteoarthritis.
Findlay DM, Kuliwaba JS
Bone research 2016; (4()):16028 doi:10.1038/boneres.2016.28.
PMID: 27672480
6
Changes to the activity and sensitivity of nerves innervating subchondral bone contribute to pain in late-stage osteoarthritis.
Morgan M, Thai J, Nazemian V, et al.
Pain 2022; (163(2)):390-402 doi:10.1097/j.pain.0000000000002355.
PMID: 34108432
7
Subchondral bone microenvironment in osteoarthritis and pain.
Hu Y, Chen X, Wang S, et al.
Bone research 2021; (9(1)):20 doi:10.1038/s41413-021-00147-z.
PMID: 33731688
8
Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12.
Lin C, Liu L, Zeng C, et al.
Bone research 2019; (7()):5 doi:10.1038/s41413-018-0041-8.
PMID: 30792936
9
Synovitis in osteoarthritis: current understanding with therapeutic implications.
Mathiessen A, Conaghan PG
Arthritis research & therapy 2017; (19(1)):18 doi:10.1186/s13075-017-1229-9.
PMID: 28148295
10
The role of Th/Treg immune cells in osteoarthritis.
Wen Z, Qiu L, Ye Z, et al.
Frontiers in immunology 2024; (15()):1393418 doi:10.3389/fimmu.2024.1393418.
PMID: 39364408
11
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis.
Latourte A, Cherifi C, Maillet J, et al.
Annals of the rheumatic diseases 2017; (76(4)):748-755 doi:10.1136/annrheumdis-2016-209757.
PMID: 27789465
12
Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis.
Kondreddy V, Banerjee R, Devi BLAP, et al.
Cell communication and signaling : CCS 2024; (22(1)):189 doi:10.1186/s12964-024-01547-4.
PMID: 38519981
13
Global prevalence, incidence, and years lived with disability (YLDs) of osteoarthritis: trends from 1990 to 2021 and projections to 2050.
Chen M, Chen S, Xie C, et al.
Journal of orthopaedic translation 2026; (56()):101029 doi:10.1016/j.jot.2025.11.005.
PMID: 41836571
14
Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

The Lancet. Rheumatology 2023; (5(9)):e508-e522 doi:10.1016/S2665-9913(23)00163-7.
PMID: 37675071
15
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017.
Safiri S, Kolahi AA, Smith E, et al.
Annals of the rheumatic diseases 2020; (79(6)):819-828 doi:10.1136/annrheumdis-2019-216515.
PMID: 32398285
16
Mesenchymal stem cells in osteoarthritis therapy: a review.
Zhu C, Wu W, Qu X
American journal of translational research 2021; (13(2)):448-461.
PMID: 33594303
17
Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies.
Cui A, Li H, Wang D, et al.
EClinicalMedicine 2020; (29-30()):100587 doi:10.1016/j.eclinm.2020.100587.
PMID: 34505846
18
Fear of Movement and Associated Factors Among Adults With Symptomatic Knee Osteoarthritis.
Gunn AH, Schwartz TA, Arbeeva LS, et al.
Arthritis care & research 2017; (69(12)):1826-1833 doi:10.1002/acr.23226.
PMID: 28371481
19
Association of kinesiophobia with pain, disability and functional limitation in adults with knee osteoarthritis: A systematic review and meta-analysis.
Lozano-Meca J, Gacto-Sánchez M, Montilla-Herrador J
Geriatric nursing (New York, N.Y.) 2024; (60()):481-490 doi:10.1016/j.gerinurse.2024.10.013.
PMID: 39426272
20
Is Kinesiophobia Associated With Quality of Life, Level of Physical Activity, and Function in Older Adults With Knee Osteoarthritis?
Chua SKK, Lim CJ, Pua YH, et al.
Clinical orthopaedics and related research 2025; (483(4)):667-676 doi:10.1097/CORR.0000000000003278.
PMID: 39387500
21
Mental health and health-related quality of life among adults with osteoarthritis: A national population-based study.
Alwhaibi M, Alhawassi TM
PloS one 2025; (20(6)):e0325780 doi:10.1371/journal.pone.0325780.
PMID: 40531897

This page is for informational purposes only and does not constitute medical advice. Discuss your osteoarthritis symptoms, activity plan, and treatment decisions with your healthcare professional.

Guide Contents